Sepsis – Epidemiology – Mature Markets

Clarivate Epidemiology’s coverage of sepsis comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the incidence of sepsis for each country, as well as annualized case counts projected to the national population.

Clarivate Epidemiology’s sepsis forecast will answer the following questions:

  • How will demographic trends such as population aging and improving life expectancy affect the epidemiology of sepsis over the forecast period?
  • Of all people diagnosed with sepsis, how many in each of the mature pharmaceutical markets are drug-treated?

All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as a part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

Clarivate Epidemiology provides at least 10 years of forecast data for the following sepsis patient populations:

  • Diagnosed events.
  • Diagnosed events by severity.
  • Severe sepsis by primary site of infection.
  • Severe sepsis by pathogen.

Note: Coverage may vary by country and region.